Kyndryl Holdings Inc vs Novo Nordisk A/S — how do they compare? Kyndryl Holdings Inc trades at $13.26 (market cap $2.91B), while Novo Nordisk A/S trades at $45.93 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 71.4× Kyndryl Holdings Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Kyndryl Holdings Inc pays none. Which is the better fit depends on your goals.
| KD | NVO | |
|---|---|---|
Market Cap | $2.91B | $207.85B |
Sector | Technology | Health |
52-Week High | $33.14 | $63.98 |
52-Week Low | $10.59 | $35.29 |
Enterprise Value | $5.74B | $222.55B |
Dividend Yield | — | 3.81% |
Trailing returns across standard periods
Latest headlines on both assets
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →